Regency Capital Management Inc.\De I Teos Therapeutics, Inc. Transaction History
Regency Capital Management Inc.\De
- $188 Million
- Q2 2025
A detailed history of Regency Capital Management Inc.\De transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Regency Capital Management Inc.\De holds 58,000 shares of ITOS stock, worth $588,700. This represents 0.31% of its overall portfolio holdings.
Number of Shares
58,000Holding current value
$588,700% of portfolio
0.31%Shares
1 transactions
Others Institutions Holding ITOS
# of Institutions
144Shares Held
37.7MCall Options Held
733KPut Options Held
611K-
Eco R1 Capital, LLC San Francisco, CA10.7MShares$108 Million9.18% of portfolio
-
Tang Capital Management LLC San Diego, CA3.83MShares$38.8 Million2.28% of portfolio
-
Black Rock Inc. New York, NY3.73MShares$37.9 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY1.98MShares$20.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.66MShares$16.9 Million0.0% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $361M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...